Skip to main content
ACS AuthorChoice logoLink to ACS AuthorChoice
. 2024 Mar 5;21(4):2058. doi: 10.1021/acs.molpharmaceut.4c00176

Correction to “Reverse Iontophoresis: Noninvasive Assessment of Topical Drug Bioavailability”

Kieran Moore, Sébastien Grégoire, Joan Eilstein, M Begoña Delgado-Charro, Richard H Guy
PMCID: PMC10988549  PMID: 38441041

The units of In vitro CVT,0 and In vivo CVT,0 in Table 3 should both be μmol mL–1. The results, discussions, and conclusions in the original article are not affected by this correction.


Articles from Molecular Pharmaceutics are provided here courtesy of American Chemical Society

RESOURCES